NCT04768530

Brief Summary

The aim of the study was to assess the effect of nitazoxanide delivered subgingivally as thermosensitive hydrogel on the clinical and biochemical outcomes of SRP in patients with moderate periodontitis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Jul 2019

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 20, 2019

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2020

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2020

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

February 21, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 24, 2021

Completed
Last Updated

February 24, 2021

Status Verified

February 1, 2021

Enrollment Period

9 months

First QC Date

February 21, 2021

Last Update Submit

February 21, 2021

Conditions

Outcome Measures

Primary Outcomes (5)

  • Probing depth

    Probing depth was recorded at tested sites with graduated William's probe graduated in 1 mm increment. Readings were rounded to the nearest mm.

    up to 6 months

  • Clinical attachment loss

    Clinical attachment loss was recorded at tested sites with graduated William's probe graduated in 1 mm increment. Readings were rounded to the nearest mm.

    up to 6 months

  • Bleeding on probing

    Bleeding on probing was assessed at tested sites with graduated William's probe graduated in 1 mm increment, within 15 seconds after probing, using a dichotomous scoring system (+ and -) for presence or absence, respectively.

    up to 6 months

  • Gingival index

    Gingival index was assessed at 4 sites on six index teeth. Scores range from 0 to 3, with 0 being normal and 3 being severe inflammation

    up to 6 months

  • Biochemical assessment of inflammation

    This involved determination of the gingival crevicular fluid (GCF) levels of matrix metalloproteinase 8 (MPP-8). A GCF sample was taken from the area showing the deepest pocket depth around the treated area.The samples were diluted in phosphate buffer saline (PBS) up to 1 mL. After waiting for 15 min, the paper points were removed, and 500 μL were centrifuged at 400 g for 4 min, then frozen at -20°C pending MMP-8 analysis using Human Matrix metalloproteinase 8/Neutrophil collagenase (MMP-8) ELISA Kit according to the manufacturer instructions.

    up to 6 months

Study Arms (2)

Scaling and Root Planing (SRP)

ACTIVE COMPARATOR
Procedure: Scaling and Root Planing

Scaling and Root Planing with Nitazoxanide hydrogel

EXPERIMENTAL
Drug: Nitazoxanide hydrogel

Interventions

Supra- and sub-gingival calculus and debris were removed

Scaling and Root Planing (SRP)

Scaling and root planing was performed in combination with the subgingivally delivered thermosensitive Nitazoxanide hydrogel as adjunct antimicrobial therapy.

Scaling and Root Planing with Nitazoxanide hydrogel

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients having probing depth (PD) ≥5 mm.
  • Patients having bleeding on probing (BOP) in proximal tooth surface.
  • Patients who could maintain an O'Leary plaque index ≤10 proceeded into the study.

You may not qualify if:

  • Patients having any systemic disease that may affect the treatment outcomes.
  • Smokers.
  • Pregnant females.
  • Patients receiving contraindicated medications, chemotherapy, or radiotherapy in the previous year.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Alexandria University

Alexandria, 21527, Egypt

Location

MeSH Terms

Conditions

Periodontitis

Interventions

Tooth ExfoliationRoot Planing

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Dental Physiological PhenomenaDigestive System and Oral Physiological PhenomenaDental ScalingDental ProphylaxisPeriodonticsDentistrySubgingival CurettagePreventive Dentistry

Study Officials

  • Maha R. Taalab, PhD

    Faculty of Dentistry, Alexandria University, Egypt

    STUDY CHAIR
  • Sylvia Farid, BDS

    Faculty of Dentistry, Alexandria University, Egypt

    PRINCIPAL INVESTIGATOR
  • Shaimaa Maklad, PhD

    Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Egypt

    STUDY DIRECTOR
  • Labiba El-Khordagui, PhD

    Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Egypt

    STUDY DIRECTOR
  • Maha El Tantawi, PhD

    Faculty of Dentistry, Alexandria University, Egypt

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor, Oral Medicine, Periodontology, Oral Diagnosis and Oral Radiology department

Study Record Dates

First Submitted

February 21, 2021

First Posted

February 24, 2021

Study Start

July 20, 2019

Primary Completion

April 1, 2020

Study Completion

April 30, 2020

Last Updated

February 24, 2021

Record last verified: 2021-02

Locations